Navigation Links
Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate

-party reimbursement for Renvela™; and the risks and uncertainties described in reports filed by Genzyme with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, including without limitation the information under the heading "Risk Factors" in the Management's Discussion and Analysis of Financial Condition and Results of Operations section in Genzyme’s Quarterly Report on Form 10-Q for the period ended March 31, 2007. Genzyme cautions investors not to place substantial reliance on the forward-looking statements contained in this press release. These statements speak only as of the date of this press release, and Genzyme undertakes no obligation to update or revise these statements.


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trial of Hylastan
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
5. Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/24/2009)...irstCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS...perJaffrayHealthcareConferenceonTuesday,December1,...gheldatTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Pr...eanoverviewofAnadysanditsclinicaldevelopmentprogra...willbesimultaneouslywebcastandcanbeaccessedontheIn...
(Date:11/24/2009)...wire/--ZargisMedicalCorp.,asubsidiaryofSpeedusCorp...search(NYSE: SI ),todayannouncedthatitsZargisCardi...fCBS, TheEarlyShow duringasegmentinwhichMarkJannot...inningproductsfromthepublication,s2009"BestofWhat,...elevisionmorningnewstalkshowbroadcastbyCBSfromNewY...
(Date:11/24/2009)...-USNewswire/--America,spharmaceuticalresearchandbi...estotreatorpreventHIV/AIDSandrelatedconditions,acc...ResearchandManufacturersofAmerica(PhRMA).December1...renesscampaignthatoriginatedatthe1988WorldSummitof..., "Wearegreatlyencouragedbythesecriticallyimport...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 1Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 1Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 4ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 1ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 2ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 3
...wswire/ -- Mersana, a,cancer therapeutics company,...es with its lead product candidate, XMT-1001, will...eting of the,American Association of Cancer Resear...s, CA. Full text of the abstracts can be,viewed on...f=,"http://www.aacr.org/">http://www.AACR.org . , ...
...e Oncology Compounds at the,American Association f...l., April 13, 2007 /PRNewswire-FirstCall/ -- For,d...hat target,cancer. Researchers now know that cance...y require new blood vessels to deliver oxygen,and ...,(proliferation), they travel throughout the body ...
Other Medicine Technology:Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 2Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 3Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 4
(Date:11/25/2009)...e/--TwomoreH1N1vaccineclinicshavebeenscheduledforT...thDepartmentannouncedtoday.Theyarebeingofferedatno...rlingHeights. ,, TheDec.3clinicwillbeheldfromno...merosol-freeversionoftheinjectablevaccinewillbeava...andnasalsprayimmunizationwillbeoffered.Pregnantwom...
(Date:11/25/2009)...ntial to normal human development - the Wnt/Wingle...R) pathways - interact in ways that can promote tu... The University of Texas M. D. Anderson Cancer Cen... . , This newly characterized interaction involv...ith invasive cancer - activation of EGFR, elevated...
(Date:11/25/2009)... , An innovative treatment for HIV patients ...rchers has passed its first clinical trial with fl... customized for each individual patient, and was d...tute of the MUHC in collaboration with Dr. R. Skal...e made for the individual patient an "haute coutu...
(Date:11/25/2009)... to enjoy festive feasting , , WEDNESDAY...-week holiday smorgasbord from Thanksgiving to New... pounds you,ll have to sweat off come Jan. 1, help...erts, to enjoy holiday eating and make it to 201...l about devising a strategy and thinking about hol...
(Date:11/25/2009)...wswire/--/EINNews/EINNews,anonlineleaderinindustry...esthealth-relatedpublicationforindustryprofessiona...om ). ,, H1N1NewsTodaygathersthelatestinformati...andresearchcenterstheworldover,searchingbeyondthef...ithreportsfromeverystateandeverycountry. ,, Dig...
Breaking Medicine News(10 mins):Health News:Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3Health News:H1N1 News Today Examines the Swine Flu Virus From a Global Perspective; Read the Latest H1N1 Virus Vaccine & Prevention News From EIN News 2
...ations are rising and tough to get rid of, experts...) -- Although bed bugs might prevent you from slee...n,t appear to transmit illness, a new report finds...the Journal of the American Medical Association ,...
...sful Collaboration with the U.S. Army , , - U.S. ...ell,s first marketed product, a new vaccine agains...litary personnel , , - Success of Intercell,s new...act for IXIARO with the U.S. military, to be concl...
...e,s periapproval services experts to discuss REMS ...ETON, N.J., March 31 Covance Inc. (NYSE: CVD ...ment and risk evaluation and mitigation strategies...ce president of medical affairs for periapproval s...
...ON , March 31 The following is a statement from...merica,s Health (TFAH): , , Today,s recall of pis...ur food safety system is. Our current food safety ...urced, and understaffed. It is encouraging that th...
...y Tracking Tools Bring Women Together To Share and... March 31 23andMe , Inc., an industry leader i...aunched a free pregnancy community and research ...all women. , , Moms of all ages are welcome to pa...
... ConsumerLab.com Uncovers Defects ...d Finds Most Children,s Multivitamins Exceed Toler...s, New York (PRWEB) March 31, 2009 -- Over 30% of ...inated with lead. In addition, several products (i...
Other Medicine News:Health News:Bed Bugs Bring No Disease Danger 2Health News:Bed Bugs Bring No Disease Danger 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 2Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 4Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 5Health News:Covance Experts to Present Key Insights on Risk Management at Bio/Pharmaceutical Drug Safety Forum 2Health News:Covance Experts to Present Key Insights on Risk Management at Bio/Pharmaceutical Drug Safety Forum 3Health News:Trust for America's Health on the Recall of Certain Pistachios and the U.S. Food Safety System 2Health News:23andMe Launches Free Online Community for Moms and Moms-to-Be 2Health News:23andMe Launches Free Online Community for Moms and Moms-to-Be 3Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 2Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 3Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 4Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 5
...nsfers depurinated DNA and RNA from agarose gels t...es ,Increases speed and efficiency of transfer by ...of an integrated system allowing electrophoresis, ... hours, versus 29 hours required for conventional ...
...nsfers depurinated DNA and RNA from agarose gels t...es ,Increases speed and efficiency of transfer by ...of an integrated system allowing electrophoresis, ... hours, versus 29 hours required for conventional ...
PosiBlot 30-30 Pads
Liquid Trap
Medicine Products: